1. Home
  2. HEQ vs VANI Comparison

HEQ vs VANI Comparison

Compare HEQ & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$11.30

Market Cap

139.0M

Sector

Finance

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.25

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEQ
VANI
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.0M
119.0M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
HEQ
VANI
Price
$11.30
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
20.4K
231.2K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.46
$0.92
52 Week High
$12.00
$1.92

Technical Indicators

Market Signals
Indicator
HEQ
VANI
Relative Strength Index (RSI) 42.16 40.80
Support Level $11.29 $1.26
Resistance Level $11.63 $1.55
Average True Range (ATR) 0.17 0.08
MACD -0.03 -0.02
Stochastic Oscillator 4.44 3.74

Price Performance

Historical Comparison
HEQ
VANI

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return, with a focus on current income and gains, and to include long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: